Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Pancreatic Cancer, Surgical Outcomes Neoadjuvant

Matthew Katz

MD

🏢MD Anderson Cancer Center🌐USA

Professor of Surgery

43
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Matthew Katz is a surgical oncologist at MD Anderson focused on pancreatic cancer resection after neoadjuvant therapy. He has published landmark analyses of R0 resection rates and long-term survival in borderline resectable pancreatic cancer treated with preoperative FOLFIRINOX or chemoradiation. His work has contributed to defining surgical eligibility criteria after neoadjuvant treatment and optimizing the multidisciplinary perioperative workflow.

Share:

🧪Research Fields 研究领域

pancreatic surgery after neoadjuvant therapy
pancreatectomy resection margins
borderline resectable PDAC outcomes
preoperative chemoradiation pancreas
R0 resection neoadjuvant pancreas

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Matthew Katz 的研究动态

Follow Matthew Katz's research updates

留下邮箱,当我们发布与 Matthew Katz(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment